Modified Citrus Pectin Benefits
If you fear getting prostate cancer, or have high levels of cholesterol, you might want to consider modified citrus pectin (MCP), which can help curb the development of both disorders. MCP, which can be found on jelly used for toast, helps with detoxification, immune function modulation and cancer cell proliferation inhibition.
Other People Are Reading
-
Modified Citrus Pectin (MCP) Defined
-
Regular pectin is found in plants, as well as the peels of a number of fruits (citrus fruits, plums, and apples). It is a carbohydrate comprised of thousands of sugar molecules, which make it impossible to be absorbed by the body, thus hindering any potential health benefits that could be derived from its use.
According to the American Cancer Society (see link in the Resources Section below), modified citrus pectin (MCP) is merely an altered type of pectin. MCP is able to be absorbed through the blood stream since it takes pectin sugar molecules and breaks them apart into much smaller quantities, which makes absorption possible.
MCP Benefit: Halting Cancer Cell Proliferation
-
MCP is believed to provide many benefits, but the most notable thus far has been its ability to slow the progression--or stop intrusion--of cancerous cell proliferation into other organs besides the initial cancer site. According to the American Cancer Society, both animal studies and uncontrolled studies involving humans seem to support these findings, at least in regards to prostate and skin cancers.
-
Other MCP Benefits
-
The reduction of serum cholesterol levels and the strengthening of T-cells (which kill cancer and also fight germs) are two more MCP benefits. But that's not all, MCP is also known for aiding the immune system as well as helping with the detoxification of the body. It has also been credited for preventing cancer metastases in the breast and lungs too.
Lead Reduction in Children Benefit
-
A study conducted by the United States Department of Agriculture--published in July of 2008--supports the premise that MCP could play a future role in becoming the needed agent in the heavy metal chelating process (elimination of lead from the body) of children.
Lead Study Details
-
The study (see link in the Resources Section below) was conducted on children who were hospitalized with heavy lead concentrations. Fifteen grams of MCP were administered orally to hospitalized children 5 to 12 years old, who had a lead toxicity level exceeding 20 pg/dl and had not received any other chelating or detoxification assistance for three months prior to the study.
The results revealed overall reduction of lead blood levels, through increased urine output, according to the USDA, and warrant greater consideration of MCP in the fight against child lead toxicity.
-
